General Information of Drug Off-Target (DOT) (ID: OT9Q5YSN)

DOT Name Adapter molecule crk (CRK)
Synonyms Proto-oncogene c-Crk; p38
Gene Name CRK
UniProt ID
CRK_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
1JU5; 2DVJ; 2EYV; 2EYW; 2EYX; 2EYY; 2EYZ; 2MS4; 5UL6; 6ATV
Pfam ID
PF00017 ; PF00018 ; PF07653
Sequence
MAGNFDSEERSSWYWGRLSRQEAVALLQGQRHGVFLVRDSSTSPGDYVLSVSENSRVSHY
IINSSGPRPPVPPSPAQPPPGVSPSRLRIGDQEFDSLPALLEFYKIHYLDTTTLIEPVSR
SRQGSGVILRQEEAEYVRALFDFNGNDEEDLPFKKGDILRIRDKPEEQWWNAEDSEGKRG
MIPVPYVEKYRPASASVSALIGGNQEGSHPQPLGGPEPGPYAQPSVNTPLPNLQNGPIYA
RVIQKRVPNAYDKTALALEVGELVKVTKINVSGQWEGECNGKRGHFPFTHVRLLDQQNPD
EDFS
Function
Involved in cell branching and adhesion mediated by BCAR1-CRK-RAPGEF1 signaling and activation of RAP1; [Isoform Crk-II]: Regulates cell adhesion, spreading and migration. Mediates attachment-induced MAPK8 activation, membrane ruffling and cell motility in a Rac-dependent manner. Involved in phagocytosis of apoptotic cells and cell motility via its interaction with DOCK1 and DOCK4. May regulate the EFNA5-EPHA3 signaling.
KEGG Pathway
MAPK sig.ling pathway (hsa04010 )
ErbB sig.ling pathway (hsa04012 )
Rap1 sig.ling pathway (hsa04015 )
Chemokine sig.ling pathway (hsa04062 )
Efferocytosis (hsa04148 )
Focal adhesion (hsa04510 )
Fc gamma R-mediated phagocytosis (hsa04666 )
Neurotrophin sig.ling pathway (hsa04722 )
Regulation of actin cytoskeleton (hsa04810 )
Insulin sig.ling pathway (hsa04910 )
Growth hormone synthesis, secretion and action (hsa04935 )
Bacterial invasion of epithelial cells (hsa05100 )
Shigellosis (hsa05131 )
Yersinia infection (hsa05135 )
Human cytomegalovirus infection (hsa05163 )
Human immunodeficiency virus 1 infection (hsa05170 )
Pathways in cancer (hsa05200 )
MicroR.s in cancer (hsa05206 )
Re.l cell carcinoma (hsa05211 )
Chronic myeloid leukemia (hsa05220 )
Reactome Pathway
Downstream signal transduction (R-HSA-186763 )
Regulation of actin dynamics for phagocytic cup formation (R-HSA-2029482 )
p130Cas linkage to MAPK signaling for integrins (R-HSA-372708 )
VEGFA-VEGFR2 Pathway (R-HSA-4420097 )
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases (R-HSA-8849471 )
MET activates RAP1 and RAC1 (R-HSA-8875555 )
MET receptor recycling (R-HSA-8875656 )
Regulation of signaling by CBL (R-HSA-912631 )
FCGR3A-mediated phagocytosis (R-HSA-9664422 )
ARMS-mediated activation (R-HSA-170984 )

Molecular Interaction Atlas (MIA) of This DOT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
This DOT Affected the Drug Response of 1 Drug(s)
Drug Name Drug ID Highest Status Interaction REF
Fluorouracil DMUM7HZ Approved Adapter molecule crk (CRK) affects the response to substance of Fluorouracil. [8]
------------------------------------------------------------------------------------
5 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Adapter molecule crk (CRK). [1]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Adapter molecule crk (CRK). [2]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of Adapter molecule crk (CRK). [3]
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of Adapter molecule crk (CRK). [4]
Deguelin DMXT7WG Investigative Deguelin decreases the expression of Adapter molecule crk (CRK). [7]
------------------------------------------------------------------------------------
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Adapter molecule crk (CRK). [5]
PMID28870136-Compound-52 DMFDERP Patented PMID28870136-Compound-52 decreases the phosphorylation of Adapter molecule crk (CRK). [6]
------------------------------------------------------------------------------------

References

1 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
2 Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
3 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
4 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
5 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
6 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
7 Neurotoxicity and underlying cellular changes of 21 mitochondrial respiratory chain inhibitors. Arch Toxicol. 2021 Feb;95(2):591-615. doi: 10.1007/s00204-020-02970-5. Epub 2021 Jan 29.
8 Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations. Int J Cancer. 2006 Apr 1;118(7):1699-712. doi: 10.1002/ijc.21570.